Christopher S. Boerner

Christopher S. Boerner

DirectoratBristol Myers Squibb· In proxies 2021–2025

Pay in FY2025+16% from the year before

Christopher S. Boerner was paid $21.9M in FY2025 (Dec), up 16%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Bristol Myers Squibb proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Colgate PalmolivePublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. Bristol Myers SquibbPublic company · 5 yr
    • Board Chair and Chief Executive Officer2021 – Present · 5 yrNo stock prices for these years
  3. Corporate Governance Committee of Achaogen, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Achaogen, Inc.Public company · 1 yr
    • Director2014 – 2015 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?